BioCatalystWatch
SBFMWorkspace / SBFM / OverviewCompany library
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc.

Sunshine Biopharma Inc. (SBFM)

Website

Featured programme · lead Coronavirus drug candidate

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Aromatase

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Aromatase

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

SBFM-PL4 COVID-19 treatment

PLpro × Mpro

PreINDP1P2P3FilingApproved
two Anti-Coronavirus compounds

Coronavirus protease

PreINDP1P2P3FilingApproved
K1.1 mRNA Lipid Nanoparticle

PreINDP1P2P3FilingApproved
K1.1

PreINDP1P2P3FilingApproved

Approved / commercial

Approved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

History / paused

Topoisomerase II (Topo II)

PreINDP1P2P3FilingApproved

Topoisomerase II (Topo II)

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SBFM PR & News

PR & News

SBFM SEC archive